Mohammad Awlad Mohammad | Oncology Pharmaceuticals | Research Excellence Award Published on 08/04/2026 by Top Pharmaceutical Dr. Mohammad Awlad Mohammad | Oncology Pharmaceuticals | Research Excellence Award Al-Quds University | Palestine Dr. Mohammad Awlad Mohammad is a medical doctor and emerging researcher affiliated with the Faculty of Medicine at Al-Quds University, specializing in clinical medicine and translational research. He completed his medical degree with a strong academic record, complemented by advanced training in scientific writing, systematic reviews, and research ethics. His clinical experience includes surgical electives and pathology observerships, where he developed practical competencies in operative assistance, diagnostic workflows, and patient-centered care. Actively engaged in research, his work focuses on clinical case studies, oncology disparities, neurological therapeutics, and evidence-based analysis, contributing as both first and co-author to peer-reviewed publications, including studies on acute appendicitis atypical presentation and thoracic oncology disparities, alongside ongoing projects in multiple sclerosis and GLP-1 receptor agonists. He has demonstrated leadership through participation in research camps and academic collaborations, strengthening interdisciplinary inquiry. His certifications in Basic and Advanced Cardiac Life Support and research training programs reflect a commitment to clinical excellence and scientific integrity, positioning him as a promising contributor to advancing medical research and practice. View ORCID Profile Top Featured Publications Disparities in Thoracic Oncology Patients Acute Appendicitis Presented with Testicular Pain Only
Chao Song | Drug Discovery and Development | Pharmaceutical Excellence Award Published on 08/04/202608/04/2026 by Top Pharmaceutical Mr. Chao Song | Drug Discovery and Development | Pharmaceutical Excellence Award Guangxi Traditional Chinese Medical University | China Mr. Chao Song is a PhD researcher at Guangxi University of Traditional Chinese Medicine, specializing in pharmacology, molecular biology, and translational medicine. He holds advanced academic training in biomedical sciences with a focus on traditional Chinese medicine and intervertebral disc disorders. His professional experience includes active participation in multiple provincial and municipal research projects, demonstrating strong collaborative and leadership capabilities in scientific investigations. His research primarily explores intervertebral disc degeneration, immune regulation, cellular senescence, and multi-omics integration, with contributions spanning network pharmacology, metabolomics, and metagenomics. He has authored numerous high-impact SCI publications, including first-author and corresponding-author works in leading journals, reflecting significant influence in his field. His technical expertise includes advanced experimental and analytical methods such as molecular assays, cell and animal studies, and scientific data visualization. His scholarly contributions have been recognized through competitive research funding, patent development, and consistent publication in high-impact journals, underscoring his growing reputation and commitment to advancing pharmaceutical and biomedical research. Citation Metrics (Google Scholar) 643 480 320 160 0 643 50 11 Citations Documents h-index View Scopus Profile Top 5 Featured Publications Mitochondrial Dysfunction: A New Molecular Mechanism of Intervertebral Disc Degeneration – Inflammation Research Cellular Senescence: Molecular Mechanisms of Intervertebral Disc Degeneration from an Immune Perspective – Biomedicine & Pharmacotherapy An In-Depth Analysis of the Immunomodulatory Mechanisms of Intervertebral Disc Degeneration – JOR Spine Bioinformatics-Based Discovery of Intervertebral Disc Degeneration Biomarkers and Immune-Inflammatory Infiltrates – JOR Spine Cellular Senescence and Immune Regulation in Intervertebral Disc Degeneration – PubMed Indexed Article
Shanshan Guo | Pharmacology | Research Excellence Award Published on 08/04/2026 by Top Pharmaceutical Dr. Shanshan Guo | Pharmacology | Research Excellence Award Principal Investigator | China Academy of Chinese Medical Sciences | China Dr. Shanshan Guo is a Principal Investigator and Director at the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, specializing in pharmacology and integrative medicine with a focus on Chinese materia medica and respiratory diseases. She holds advanced degrees in traditional Chinese medicine, integrated Chinese and Western medicine, and pharmacology, reflecting a strong interdisciplinary academic foundation. Her professional career demonstrates progressive leadership, including roles as Principal Investigator and research lead, where she has directed major pharmacological research initiatives and innovative experimental platforms. Her research centers on antiviral therapeutics, mechanisms of pathogen-host interaction, and safety evaluation of traditional Chinese medicine, supported by extensive publications and impactful contributions to translational medicine. She has successfully led funded projects on broad-spectrum antiviral agents and pharmacodynamic mechanisms of herbal formulations, highlighting her scientific rigor and innovation. Dr. Guo’s work has earned recognition through competitive research funding, leadership responsibilities, and contributions to advancing evidence-based integration of traditional and modern medicine, positioning her as a significant contributor to global pharmaceutical and biomedical research. Citation Metrics (Google Scholar) 745 560 375 190 0 745 116 15 Citations Documents h-index View Scopus Profile Top 5 Featured Publications Attenuate Host Susceptibility to Respiratory Virus Invasion by Inhibiting Interactions Between Host Proteins SLC16A3 and AP1G1 – Microbiology Spectrum Verbenalin Protects Against Coronavirus Pneumonia by Promoting Host Immune Homeostasis – Phytomedicine An advanced network pharmacology investigation of Shufeng Jiedu formula in the treatment for respiratory tract infection based on LC–MS, data mining, molecular docking, and molecular dynamic simulation – Frontiers / Open Access Platform Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice – Pharmacological Review Pharmacological effects and mechanisms of Xuanfei Baidu Decoction in the treatment of viral pneumonia – Chinese Journal of Pharmacovigilance
Chattar Singh Yadav | Pharmaceutical Manufacturing | Pharmaceutical Excellence Award Published on 08/04/202608/04/2026 by Top Pharmaceutical Dr. Chattar Singh Yadav | Pharmaceutical Manufacturing | Pharmaceutical Excellence Award Senior Manager | Aurobindo Pharma Limited | India Dr. Chattar Singh Yadav is a researcher at Aurobindo Pharma, India, specializing in pharmaceutical sciences with a focus on applied research and drug development. He holds advanced academic training in pharmaceutical disciplines, with specialization in areas aligned to pharmacological and formulation sciences. His professional experience includes contributions to industry-oriented research projects, supporting the development and evaluation of pharmaceutical products while demonstrating active involvement in collaborative and technical roles. His research focus encompasses formulation strategies, drug analysis, and applied pharmacokinetics, reflected in a growing body of publications and measurable citation impact. Dr. Yadav’s work contributes to the advancement of practical and scalable solutions in the pharmaceutical domain. He has received recognition for his research contributions through citation-based metrics and continues to build his academic profile through ongoing research engagement. He is also associated with scholarly activities, contributing to the scientific community through research dissemination and professional participation, indicating strong potential for future impact and leadership in pharmaceutical research. Citation Metrics (Google Scholar) 39 30 20 10 0 39 2 1 Citations h-index i10-index View Google Scholar Profile Featured Publications Journal of Global Pharma Technology: Microsponge a novel carrier for cosmetics – Journal of Global Pharma Technology Microsponge a novel carrier for cosmetics – Journal of Scientific Research in Pharmacy Development of Rapid Disintegrating Modified Release Carbamazepine Tablet by Novel Particle Coating Technology – Pharma Research (Article)
Wei Li | Nanotechnology | Research Excellence Award Published on 08/04/2026 by Top Pharmaceutical Dr. Wei Li | Nanotechnology | Research Excellence Award Associate Researcher | Chongqing University | China Dr. Wei Li is a distinguished researcher at Chongqing University, China, specializing in advanced scientific research with a strong focus on impactful and innovative contributions within the field. Holding advanced degrees with specialization in his research domain, he has developed a solid academic foundation that supports his scholarly excellence. His professional experience includes significant roles in research projects, collaborative initiatives, and academic leadership, demonstrating his ability to contribute effectively to scientific advancement. Dr. Li’s research focuses on producing high-quality publications that have garnered substantial citations, reflecting the relevance and influence of his work in the academic community. He has contributed to various peer-reviewed journals and actively engages in advancing knowledge through research dissemination. His achievements include recognition for research excellence, along with involvement in academic and professional communities through editorial contributions and scholarly memberships. His consistent performance and dedication position him as a strong candidate for prestigious academic recognition. Citation Metrics (Google Scholar) 244 180 120 60 0 244 28 10 Citations Documents h-index View Scopus Profile View ORCID Profile Top 5 Featured Publications A DNA-based nanodevice senses purinergic signaling and drives an immune switch for resolving inflammation – Nature Communications Inflammation-specific DNA origami nanodevice for delivery of siRNAs to treat ulcerative colitis – Nature Communications Target-Mediated EV-SNA Clustering as an Amplifier for In Situ miRNA Imaging in Living Cells – Nano Letters Engineering DNA Condensate Droplets as a Versatile Nanovector – Nano Letters Targeted imaging of lysosomal zinc ions with a tetrahedral DNA framework fluorescent reporter – National Science Review
Piera Di Martino | Cosmetology | Excellence in Research Award Published on 10/03/2026 by Top Pharmaceutical After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 2606 Register Here
FENG YANG | Neuropharmacology | Innovative Research Award Published on 10/03/2026 by Top Pharmaceutical After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 2605 Register Here
Chang Yeol Lee | Molecular Diagnostics | Research Excellence Award Published on 06/03/2026 by Top Pharmaceutical After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 2601 Register Here
Srinivasaprabhu Natarajan | Pharmaceutical Marketing | Top Pharmaceutical Scientist Award Published on 27/02/2026 by Top Pharmaceutical After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 2597 Register Here
Bongani Motaung | Immunology | Excellence in Research Award Published on 17/02/2026 by Top Pharmaceutical After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 2588 Register Here